Progenics Pharmaceuticals Inc. | Key People and Executives
Mark Robert Baker
Chief Executive Officer & Director
Peter J. Crowley
Chairman
Bradley L. Campbell
Independent Director
Nicole S. Williams
Independent Director
Karen Jean Ferrante
Independent Director
Michael D. Kishbauch
Independent Director
David A. Scheinberg
Independent Director
Mark Robert Baker
Chief Executive Officer & Director
Patrick Fabbio
CFO, Principal Accounting Officer & Senior VP
Aseem Anand
Vice President-Digital Technology
Benedict Osorio
Senior Vice President-Quality
Bryce V. Tenbarge
Senior Vice President-Commercial
Jessica Jensen
Vice President-Clinical Development
Vivien Wong
Executive Vice President-Development
Thomas Strack
Vice President-Clinical Affairs
Melissa Downs
Investor Relations Contact
Peter J. Crowley
Chairman
Bradley L. Campbell
Independent Director
Nicole S. Williams
Independent Director
Karen Jean Ferrante
Independent Director
Michael D. Kishbauch
Independent Director
David A. Scheinberg
Independent Director
| Address |
One World Trade Center
New York New York 1000
United States
|
|
Employees
|
- |
| Website |
http://www.progenics.com |
| Updated |
07/08/2019 |
| Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. |
